CatalystWireBeta

UK small-cap RNS · 15 Jan 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.

Sort: Newest · Largest companies
  1. 15:02
    Replacement - Trading Update Trading update
    FY2025 revenue rose 33% in KZT on 21% higher volumes and 10% higher prices, with the plant at maximum capacity, so growth is now limited by capacity. USD price was slightly lower.
    Project milestones outlook positive +7.9% on the day
    Moved: Clinker line 6 capacity expansion: Decided; debt financing and EPC contractors pending → Decided; costed at USD 35m; financing and contractors pending
  2. 10:45
    Trading Update, Board Changes and Investment Plan Trading update
    Chair Xavier Blutel steps down and CEO Javier del Ser moves up to Executive Chairman. This is an internal reshuffle that combines the chair and executive roles, and the board stays small.
    Project milestones outlook positivefirst since Oct 2023 +7.9% on the day
    Moved: new: Clinker line 6 capacity expansion – Decided; debt financing and EPC contractors pending
  3. 07:01
    Trading Update Trading update
    15 January 2026: Abingdon Health plc (AIM: ABDX), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, provides its half-year trading update for the six months ended 31 December 2025.
    in linefirst since Oct 2023 +0.0% on the day
  4. 07:00
    Trading Update Trading update
    Fuller, Smith & Turner PLC (FSTA) Fuller, Smith & Turner PLC: Trading Update 15-Jan-2026 / 07:00 GMT/BST 15 January 2026 FULLER, SMITH & TURNER P.L.C.
    +2.0% on the day
  5. 07:00
    Full Year Trading Update Trading update
    ("DF Capital" or the "Company" together with its subsidiaries the "Group")
    Upgrade / downgrade cycle ahead of expectations +7.3% on the day
  6. 07:00
    Full Year 2025 Trading Update Trading update
    This is a full-year trading update, not a guidance raise. Adjusted EBITDA is above consensus, constant-currency revenue is in line, and FY 2026 growth of 25% is guided for the first time. Reported revenue is below the £39.5m consensus.
    Upgrade / downgrade cycle £38.5m · 23% of mcapin lineoutlook positive +10.2% on the day
    Moved: new: FY 2026 revenue growth guidance – 25% FY 2026 revenue growth guided
  7. 07:00
    Q4 2025 Trading Update Trading update
    Q4 NFI fell 14% with 2025 down 14%, and 2026 NFI is planned slightly below 2025. UK, Spain and ANZ are recovering, but northern Europe is weak. Costs and net cash are steady.
    Upgrade / downgrade cycle outlook mixed −5.5% on the day
    Moved: new: Cost savings and portfolio management – Run rate below £24m; £10m target by 2027 · new: Market recovery and 2026 NFI – 2026 NFI planned slightly below 2025
  8. 07:00
    Full Year Trading Statement 2025 Trading update
    2025 EPS beat guidance and the 2027 Homebuilding output target rises to about 2,000 units from 1,900. 2026 EPS guidance is up to 21 cent, against 20.0 cent in 2025.
    ahead of expectationsoutlook positive, raised +0.3% on the day
    Moved: new: Share buyback programme – New €25m programme started 15 January 2026 · new: Land sales programme – €55m sold in 2025; more contracted or negotiating
  9. 07:00
    Unaudited Year End Trading Update and Acquisition Trading update
    Buys Milton Keynes lettings-led agent Cauldwell (c.two-thirds Lettings) for £6.5m EV, adding recurring revenue and a commuter-town hub; it is completed, not just agreed, and lifts net debt from c.£17m.
    £6.5m · 6% of mcapoutlook mixedfirst since Oct 2023 −6.0% on the day
    Moved: FY2025 profit guidance range: Range £21.5m-£23.2m, below consensus → FY2025 adjusted operating profit c.£22m, within range (closed) · Head office relocation cost savings: Relocation being advanced → Relocation complete (closed) · Share buyback programme: Second £3m programme under way → £5.5m returned via two buybacks in 2025
  10. 07:00
    Second quarter and first half trading update Trading update
    Q2 sales slowed to +1.6% on heavy Black Friday and December competition and furniture availability problems. H1 PBT is guided to £112m-£114m and FY26 PBT to the lower end of the £214m-£227m consensus range, after October's 'in line'.
    below expectationsoutlook mixed, loweredfirst since Oct 2023 −19.5% on the day
    Moved: Digital app and brand campaign: App launched on Apple App Store; campaign live → App live on Apple and Android; full launch planned
  11. 07:00
    Trading Update Trading update
    PBT guidance lifted again from above £7.0m (11 Dec) to above £7.4m, with EBITDA above £11.8m and revenue about £63.0m, all above the December floors, driven by Playstack.
    Turnaround plan with targets £8.0m · 15% of mcapahead of expectationsoutlook positive, raised +1.7% on the day
    Moved: Record first annual Profit Before Tax in 2025.: on_track → delivered – FY25 PBT expected above £7.4m, up more than 720% from £0.9m, a record profit year. · Group to grow all profitability lines in 2025 and beyond.: on_track → delivered – Revenue, adjusted EBITDA and PBT all expected to rise in FY25 versus FY24. · Buy back up to £4m of shares by 31 December 2025.: pending → delivered – Two buybacks totalling £8.0m were completed in 2025, double the £4m target.
  12. 07:00
    First Quarter Trading Update Trading update
    Q1 LFL sales accelerated to 4.5% from 3.8% in the first eight weeks, with a very strong festive period, reinforcing momentum while the c.£130m cost headwind is reiterated and still has to be managed.
    ahead of expectationsoutlook positive +1.5% on the day
  13. 07:00
    2025 Trading Update Trading update
    Full-year adjusted EBITDA of about US$5.1m (+54%) is ahead of 2025 market expectations, with record revenue, so it beats expectations rather than formally raising company guidance.
    ahead of expectationsoutlook positivefirst in 9 months −6.6% on the day
    Moved: Strategic review and possible sale: Preliminary talks; offer period since 3 October → Review ongoing; no outcome announced
  14. 07:00
    2025 Full Year Trading Update Trading update
    Revenue rose 9% to £12.4m, but adjusted EBITDA fell to about £0.1m from £2.0m, gross margin dropped to 61% and the group moved to net debt, as investment and a corporate-heavy mix weighed on profit.
    outlook mixedfirst in 6 months −6.3% on the day
    Moved: new: Growth investment and return to cash generation – Investing; EBITDA near break-even, net debt · new: Dubai and corporate client expansion – Dubai ahead of expectations after March 2025 approval
  15. 07:00
    Q4 and FY25 Trading Update Trading update
    FY25 underlying EBITDA of £1.3m (FY24: £0.3m) is comfortably ahead of Board expectations and meets the £1.25m medium-term target, completing the turnaround phase; results remain unaudited.
    ahead of expectationsoutlook positivefirst since Oct 2023 +5.4% on the day
  16. 07:00
    FY25 Pre-close Statement Trading update
    FY25 Total Income of about £119m is above the £112.6m top of consensus, and Adjusted EBITDA is slightly above the consensus range, so the market will likely lift its forecasts.
    £119.0m · 58% of mcapahead of expectationsoutlook positivefirst since Oct 2023 +12.1% on the day
    Moved: new: International footprint expansion – New York office open; Abu Dhabi licence in principle
  17. 07:00
    Trading Statement Trading update
    Adjusted EBITDA of €19.9m matches consensus and H2 revenue growth improved after a softer start. Full-year margin fell to about 21% from 24%, and net revenue grew only 2%.
    in lineoutlook positivefirst in 6 months +2.6% on the day
    Moved: OccasionGenius integration: Acquired; integration beginning → Acquired Oct 2025; integration under way
  18. 07:00
    Trading Update Trading update
    Likewise Group plc (AIM:LIKE), the fast growing and progressive Flooring Distributor in the UK, is pleased to announce that Total Group Revenue for the year ended 31 December 2025 ("FY25") increased by 8.6% to £163.8 million.
    in line +8.0% on the day
  19. 07:00
    FY2025 Pre-close Trading Update Trading update
    Essentra plc, a leading global provider and manufacturer of essential components and solutions, today provides a trading update for the financial year ended 31 December 2025 ("FY25") and the fourth quarter covering the thirteen weeks ended 31 December 2025 …
    in line +0.9% on the day
  20. 07:00
    Savills SVS £1,749m
    Year End Trading Update Trading update
    Savills delivers good FY25 performance despite challenging markets
    in linefirst since Oct 2023 +8.8% on the day
  21. 07:00
    AGM Trading Update Trading update
    Repeats FY26 adjusted operating profit guidance in line with £24.5m consensus, with a 40/60 H1/H2 split and a £50m order book; this matches the November second-half-bias guidance, so nothing is upgraded.
    in lineoutlook positivefirst since Oct 2023 −0.7% on the day
    Moved: Ansible Motion simulator contract: Contract awarded, delivery pending → Awarded; order book includes FY27 deliveries
  22. 07:00
    Trading Statement Trading update
    Ashmore Group plc (Ashmore, the Group), the specialist Emerging Markets asset manager, announces the following update to its assets under management (AuM) in respect of the quarter ending 31 December 2025.
    +23.5% on the day
  23. 07:00
    Full Year 2025 Trading Update Trading update
    FY2025 revenue of about £228.5m (2024: £177.5m) and EBITDA of £49.5-50.0m (2024: £40.2m) meet market expectations, with surgical growth and a woundcare recovery offsetting Peters Surgical B2B destocking.
    £228.5m · 37% of mcapin lineoutlook positivefirst in 6 months +0.9% on the day
    Moved: new: Peters Surgical and Syntacoll integration – Integration on track; commercial synergies contributing · new: US market expansion – Plans for further US penetration well advanced
  24. 07:00
    Trading Update Trading update
    Confirms full-year adjusted operating profit in line with consensus (£70.2m-£73.0m) after a weak H1. Q3 I&A orders are growing, so the H2 recovery looks on course.
    Segment turn £48.5m · 4% of mcapin lineoutlook positive +5.4% on the day
    Moved: NanoScience business sale: Agreed; awaiting regulatory approvals → Completed 2 January 2026 (closed) · Imaging & Analysis recovery: H1 actions taken; H2 recovery expected → Q3 orders +2.4%; Belfast savings delivering

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note